Osteonic (Korea) Top Management
226400 Stock | KRW 4,880 140.00 2.79% |
Osteonic employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Osteonic's management performance can provide insight into the company performance.
Dong Lee CEO Chief Executive Officer, Director |
Osteonic |
Osteonic Management Team Effectiveness
Osteonic's management efficiency ratios could be used to measure how well Osteonic manages its routine affairs as well as how well it operates its assets and liabilities.Osteonic Workforce Comparison
Osteonic Co is number one stock in number of employees category among its peers. The total workforce of Health Care Equipment & Supplies industry is presently estimated at about 24.0. Osteonic totals roughly 6.0 in number of employees claiming about 25% of equities under Health Care Equipment & Supplies industry.
The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Osteonic Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Osteonic Price Series Summation is a cross summation of Osteonic price series and its benchmark/peer.
Osteonic Notable Stakeholders
An Osteonic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Osteonic often face trade-offs trying to please all of them. Osteonic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Osteonic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dong Lee | Chief Executive Officer, Director | Profile | |
Seok Choi | Assistant Managing Director | Profile | |
Seok Yoo | Internal Auditor | Profile | |
Min Lee | Assistant Managing Director | Profile | |
Tae Kim | Assistant Managing Director | Profile | |
Hyeon Choi | Director | Profile |
About Osteonic Management Performance
The success or failure of an entity such as Osteonic often depends on how effective the management is. Osteonic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Osteonic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Osteonic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. Osteonic Co., Ltd. was founded in 2012 and is based in Seoul, South Korea. OSTEONIC is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of Osteonic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Osteonic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Osteonic's management manipulating its earnings.
Osteonic Workforce Analysis
Traditionally, organizations such as Osteonic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Osteonic within its industry.Osteonic Manpower Efficiency
Return on Osteonic Manpower
Revenue Per Employee | 2.6B | |
Revenue Per Executive | 2.6B | |
Net Loss Per Employee | 475.3M | |
Net Loss Per Executive | 475.3M |
Complementary Tools for Osteonic Stock analysis
When running Osteonic's price analysis, check to measure Osteonic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Osteonic is operating at the current time. Most of Osteonic's value examination focuses on studying past and present price action to predict the probability of Osteonic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Osteonic's price. Additionally, you may evaluate how the addition of Osteonic to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |